ISOSORBIDE MONONITRATE/CILOSTAZOL FOR PREVENTING COGNITIVE AND GLOBAL DECLINE IN PATIENTS WITH LACUNAR CEREBRAL SMALL VESSEL DISEASE STROKE: SECONDARY OUTCOMES AT 6 MONTHS, LACI-2 TRIAL

Category Primary study
ConferenceEuropean Stroke Journal
Year 2023
This article has no abstract
Epistemonikos ID: 61d2edf5ad33e3c82606b9e83bd4b736ce5dcae8
First added on: Apr 30, 2026